Scarica l'app Stockscreener
22.58
4.12%
-0.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DYN Giù?
Forum
Previsione
Precedente Chiudi:
$23.55
Aprire:
$23.21
Volume 24 ore:
3.00M
Relative Volume:
1.08
Capitalizzazione di mercato:
$3.21B
Reddito:
-
Utile/perdita netta:
$-412.89M
Rapporto P/E:
-5.8497
EPS:
-3.86
Flusso di cassa netto:
$-361.93M
1 W Prestazione:
+31.89%
1M Prestazione:
+78.50%
6M Prestazione:
+91.52%
1 anno Prestazione:
-21.76%
Intervallo 1D:
$22.23
$23.34
Intervallo di 1 settimana:
$22.23
$25.00
Portata 52W:
$6.36
$35.68
Dyne Therapeutics Inc Stock (DYN) Company Profile
Nome
Dyne Therapeutics Inc
Settore
Industria
Telefono
(781) 786-8230
Indirizzo
1560 TRAPELO ROAD, WALTHAM
Confronta DYN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
22.58 | 3.35B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-25 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | Iniziato | Bernstein | Mkt Perform |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-29 | Iniziato | Evercore ISI | Outperform |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-12-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-11-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-10-24 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-21 | Reiterato | Chardan Capital Markets | Buy |
| 2024-04-30 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-20 | Iniziato | H.C. Wainwright | Buy |
| 2023-02-27 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | Iniziato | Oppenheimer | Outperform |
| 2023-01-26 | Iniziato | Guggenheim | Buy |
| 2022-07-20 | Iniziato | Chardan Capital Markets | Buy |
| 2022-07-12 | Iniziato | Raymond James | Outperform |
| 2020-10-12 | Iniziato | JP Morgan | Overweight |
| 2020-10-12 | Iniziato | Jefferies | Buy |
| 2020-10-12 | Iniziato | Piper Sandler | Overweight |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Dyne Therapeutics Inc Borsa (DYN) Ultime notizie
Historical volatility pattern of Dyne Therapeutics Inc. visualizedJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com
Sector ETF performance correlation with Dyne Therapeutics Inc.2025 Price Momentum & Smart Money Movement Tracker - newser.com
Can trapped investors hope for a rebound in Dyne Therapeutics Inc.July 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Analyzing Dyne Therapeutics Inc. with risk reward ratio charts2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Dyne Therapeutics Inc.’s volatility index tracking explainedRate Hike & Low Drawdown Investment Strategies - newser.com
Is Dyne Therapeutics Inc. stock entering bullish territory2025 Top Gainers & Reliable Volume Spike Alerts - newser.com
Technical analysis overview for Dyne Therapeutics Inc. stock2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Using RSI to spot recovery in Dyne Therapeutics Inc.2025 Winners & Losers & Technical Entry and Exit Tips - newser.com
Is Dyne Therapeutics Inc. reversing from oversold territoryPortfolio Value Summary & Fast Exit and Entry Strategy Plans - newser.com
Is Dyne Therapeutics Inc. stock gaining market share2025 Investor Takeaways & Stock Portfolio Risk Management - newser.com
What recovery options are there for Dyne Therapeutics Inc.Market Risk Analysis & Low Volatility Stock Suggestions - newser.com
Why Dyne Therapeutics Inc. stock is seen as undervaluedGDP Growth & Stock Portfolio Risk Control - newser.com
Will Dyne Therapeutics Inc. stock deliver better than expected guidance2025 Dividend Review & Safe Capital Investment Plans - newser.com
How moving averages guide Dyne Therapeutics Inc. trading2025 Year in Review & Stock Timing and Entry Methods - newser.com
Is Dyne Therapeutics Inc. stock a bargain at current levels2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today - MSN
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis - MSN
Can you recover from losses in Dyne Therapeutics Inc.Recession Risk & AI Forecast Swing Trade Picks - newser.com
Dyne Therapeutics (NASDAQ:DYN) Shares Gap UpStill a Buy? - MarketBeat
10 Big Names Crushing Wall Street - Insider Monkey
Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger - Insider Monkey
Dyne Therapeutics Inc Azioni (DYN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dyne Therapeutics Inc Azioni (DYN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna | Chief Commercial Officer |
Sep 04 '25 |
Sale |
13.27 |
894 |
11,863 |
95,017 |
| Friedl-Naderer Johanna | Chief Commercial Officer |
Sep 05 '25 |
Sale |
13.41 |
144 |
1,931 |
94,873 |
| Kerr Douglas | Chief Medical Officer |
Sep 04 '25 |
Sale |
13.27 |
3,552 |
47,135 |
89,263 |
| Kerr Douglas | Chief Medical Officer |
Sep 05 '25 |
Sale |
13.41 |
873 |
11,707 |
88,390 |
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):